Rocket Lab is no longer content to be the dependable small-satellite launcher. In the space of a week, the company has picked a fight with NASA over a contract worth up to roughly $700 million, unveiled a next-generation solar cell, flown its 96th Electron mission, and closed a $1.944 billion equity raise to fund its biggest bet yet.
A formal protest in Washington
On September 11, Rocket Lab filed a formal challenge to NASA’s decision to hand the Mars Telecommunications Network project to rival Blue Origin, according to media reports. The company alleges the award violated criteria set by Congress and that the technical review process was inconsistent. The contract carries a potential volume of about $700 million.
The move is a strategic break from the past. It signals that management is prepared to fight lengthy battles with government agencies and high-profile competitors to win lucrative work beyond low Earth orbit — a posture that raises its own question: can a specialist launch provider carry off both technical reliability and big-league ambition?
Building from the solar cell up
The push toward Mars is not an isolated gambit. It fits a deliberate vertical integration strategy in which Rocket Lab aims to control hardware, launch
The September 8 debut of the flight-ready Apex inverted metamorphic solar cell showed what in-house components are worth. By eliminating germanium substrates, the design delivers 31.5 percent efficiency at mission start while cutting cell mass by 40 percent.
Meanwhile, the operational core keeps a relentless cadence. On Saturday, an Electron rocket completed its 96th flight and 17th launch of 2026, placing the twelfth StriX radar satellite for Japan’s Synspective into a 572-kilometer orbit. That agreement locks in 15 more dedicated Synspective missions through the end of the decade. Two days earlier, on September 11, the company’s 16th mission of the year carried an Earth-observation satellite for a confidential customer into a 500-kilometer circular orbit.
The heavy lifting on the balance sheet
The real test of Rocket Lab’s transformation is financial. To fully fund its planned acquisition of satellite network operator Iridium Communications, the company completed a $1.944 billion equity placement on September 15, issuing 29.3 million shares. The previously arranged $3.6 billion secured bridge facility was scrapped. Iridium, for its part, amended its credit agreement: once the deal closes — targeted for mid-2027 — Rocket Lab USA will provide an unsecured guarantee for a $1.775 billion Iridium loan.
Should investors sell immediately? Or is it worth buying Rocket Lab?
Markets have taken note of the pace. The stock climbed 8.2 percent yesterday to close at EUR 60.90, though it still trades 54 percent below its 52-week high. A separate reading put today’s gain at 8.0 percent to EUR 60.80, with the market crediting swift progress on the company’s major projects. Rocket Lab’s market capitalization stands at EUR 35.94 billion.
Analysts are warming to the story. Raymond James initiated coverage on September 12 with an “Outperform” rating and an $80 price target, signaling confidence in the expanded business model and future scaling.
What the deal delivers — and what it costs
Supporters see the Iridium purchase as the logical route to leadership in commercial space. Marrying rocket launches with an established satellite network would reduce dependence on outside launch contracts, and the steady reliability of Electron flights provides the foundation. A smooth combination would create a space company with a direct line into communications services, potentially lifting margins over the medium term.
The risks are just as concrete. Issuing 29.3 million new shares dilutes existing holders noticeably. If the mid-2027 closing slips, investors would absorb that dilution without timely access to the hoped-for synergies. The timeline also carries antitrust and regulatory uncertainty, since space and telecom infrastructure face strict government oversight — conditions or objections in the outstanding approvals could raise costs or push the closing back. And the operational load cannot be underestimated: Rocket Lab must keep its Electron streak flawless, because any future mishap would strain resources during an already demanding integration phase.
The regulatory clock is now running
On the bureaucratic front, the FCC accepted the license transfer applications last Thursday — a necessary step in a tightly supervised approval process. Investors must now weigh whether the remaining conditions can be met without costly delays. The key metric for coming quarters will be how efficiently Rocket Lab monetizes its existing launch business while preparing the new large segment.
As long as confidence in a clean Iridium closing holds, attention should stay on Electron’s launch cadence. If the schedule slips on unexpected regulatory delays, a reassessment of integration risk looms. For shareholders, the acquisition marks a strategic fork between operational growth and a complex large-scale merger. The next concrete catalyst lies in progress on the remaining closing conditions and confirmation of further launch dates in this year’s program. Until the mid-2027 completion, the stock remains tightly tethered to regulatory developments.
Ad
Rocket Lab Stock: Buy or Sell?! New Rocket Lab Analysis from September 22 delivers the answer:
The latest Rocket Lab figures speak for themselves: Urgent action needed for Rocket Lab investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from September 22.
Rocket Lab: Buy or sell? Read more here...
